Keyphrases
NL63
100%
Vaccine Vector
50%
Heterologous Vaccine
50%
Target Gene Expression
50%
Developing World
33%
Mucosal Epithelial Cells
33%
Simultaneous Expression
33%
Regulated Expression
33%
Human Coronavirus NL63
33%
Vaccine Technology
16%
Vaccine Platform
16%
Upper Airway
16%
Respiratory Infection
16%
Lower Airways
16%
Gastrointestinal Infection
16%
Cell Lining
16%
Cellular Immune Response
16%
Respiratory Pathogens
16%
Cause of Death
16%
Native Protein
16%
Mucosal Immune Response
16%
Recombination
16%
Intellectual Property
16%
Global Health
16%
Replication-deficient
16%
Access to Vaccines
16%
Human Health
16%
Multiple Vaccine
16%
Young children
16%
Coronavirus
16%
Humoral Immune Response
16%
Genome Organization
16%
Vaccine Antigen
16%
Evolutionary Genomics
8%
Vaccine Evaluation
8%
Next-generation Vaccines
8%
Specific Intent
8%
Global Public Health
8%
Molecular Clone
8%
Public Health
8%
Virus Vaccine
8%
Computer Design
8%
Human Coronavirus (HCoV)
8%
Health Relevance
8%
Vaccine Development
8%
Reverse Genetics
8%
Medicine and Dentistry
Public Health
100%
Gene Expression
100%
Human Coronavirus NL63
50%
Pathogen
50%
Respiratory Tract Infection
50%
Toddlers
50%
Cellular Immunity
50%
Gastrointestinal Infection
50%
Humoral Immunity
50%
Epithelial Cell
50%
Coronavirinae
50%
Single Drug Dose
50%
Revertant
50%
Genome Analysis
50%
Coronaviridae
25%
Virus Vaccine
25%
Immunology and Microbiology
Gene Expression
100%
Vaccine Efficacy
100%
Heterologous Vaccine
27%
Human Coronavirus NL63
18%
Infectious Agent
18%
Revertant
18%
Coronavirinae
18%
Adoptive Immunity
18%
Humoral Immunity
18%
Virus Vaccine
9%
Coronaviridae
9%